Home/Filings/4/0001209191-21-037764
4//SEC Filing

Queva Christophe 4

Accession 0001209191-21-037764

CIK 0001671818other

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 5:15 PM ET

Size

7.0 KB

Accession

0001209191-21-037764

Insider Transaction Report

Form 4
Period: 2021-06-01
Queva Christophe
CSO and SVP, Research
Transactions
  • Sale

    Common Stock

    2021-06-01$16.69/sh12,899$215,28458,282 total
  • Sale

    Common Stock

    2021-06-02$16.66/sh10,656$177,52947,626 total
Footnotes (3)
  • [F1]Shares were sold pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.51 to $16.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.16 to $17.105 inclusive.

Issuer

Oncorus, Inc.

CIK 0001671818

Entity typeother

Related Parties

1
  • filerCIK 0001826523

Filing Metadata

Form type
4
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:15 PM ET
Size
7.0 KB